AtriCure, Inc. is a medical device company that provides innovative solutions designed to decrease the global Afib epidemic. AtriCureās IsolatorĀ® Synergyā¢ Ablation System is the first and only surgical device approved for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. AtriCureās AtriClipĀ® Left Atrial Appendage Management (LAAM) exclusion device is the most widely sold device worldwide that is indicated for the occlusion of the left atrial appendage. AtriCure believes electrophysiologists and cardiothoracic surgeons are adopting its technologies for the treatment of Afib and reduction of Afib related complications. Afib affects more than 33 million people worldwide.
AtriCure does not collect, maintain or disseminate PII from individuals who subscribe or visit AtriCureās YouTube channel. Individuals who seek information about how YouTube uses their PII should review YouTubeās Terms and Privacy Policy.